105 related articles for article (PubMed ID: 8854756)
1. Regional immunotherapy for liver metastases and the potential of TNF alpha in hepatic perfusion from laboratory to the clinic.
Eggermont AM
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1371-8. PubMed ID: 8854756
[No Abstract] [Full Text] [Related]
2. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
[TBL] [Abstract][Full Text] [Related]
3. Regional IL-2-based immunochemotherapy of colorectal liver metastases.
Okuno K; Kaneda K; Yasutomi M
Hepatogastroenterology; 1999 May; 46 Suppl 1():1263-7. PubMed ID: 10429972
[No Abstract] [Full Text] [Related]
4. The past decade of experience with isolated hepatic perfusion.
Grover A; Alexander HR
Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
[TBL] [Abstract][Full Text] [Related]
5. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.
Lindnér P; Fjälling M; Hafström L; Kierulff-Nielsen H; Mattsson J; Scherstén T; Rizell M; Naredi P
Eur J Surg Oncol; 1999 Apr; 25(2):179-85. PubMed ID: 10218462
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor and isolated hepatic perfusion: from preclinical tumor models to clinical studies.
de Vries MR; ten Hagen TL; Marinelli AW; Eggermont AM
Anticancer Res; 2003; 23(2C):1811-23. PubMed ID: 12820463
[No Abstract] [Full Text] [Related]
7. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
[TBL] [Abstract][Full Text] [Related]
8. An improved technique for regional perfusion chemotherapy in the presence of a replaced right hepatic artery using a single implantable pump.
Hughes KS; Villella ER
Surgery; 1984 Mar; 95(3):355-7. PubMed ID: 6701793
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic isolated hepatic perfusion for the treatment of unresectable cancers confined to the liver.
Carroll NM; Alexander HR
J Surg Oncol; 2002 May; 80(1):64-5; author reply 66-7. PubMed ID: 11967911
[No Abstract] [Full Text] [Related]
10. [Tumor necrosis factor-alpha--phase I and phase II clinical trials].
Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K
Pol Merkur Lekarski; 1997 Jun; 2(12):396-9. PubMed ID: 9424335
[TBL] [Abstract][Full Text] [Related]
11. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ
Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282
[TBL] [Abstract][Full Text] [Related]
12. Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms.
Alexander HR; Brown CK; Bartlett DL; Libutti SK; Figg WD; Raje S; Turner E
Clin Cancer Res; 1998 Oct; 4(10):2357-62. PubMed ID: 9796965
[TBL] [Abstract][Full Text] [Related]
13. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors.
Nakamoto T; Inagawa H; Takagi K; Soma G
Anticancer Res; 2000; 20(6A):4087-96. PubMed ID: 11131677
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the treatment of colorectal liver metastases.
Jain S; Sacchi M; Vrachnos P; Lygidakis NJ; Andriopoulou E
Hepatogastroenterology; 2005; 52(65):1567-84. PubMed ID: 16201121
[TBL] [Abstract][Full Text] [Related]
15. [Clinical probes using tumor necrosis factor in treatment of neoplastic diseases].
Szczepanik A; Tabor J; Siedlar M
Przegl Lek; 1994; 51(11):497-500. PubMed ID: 7871196
[TBL] [Abstract][Full Text] [Related]
16. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
[TBL] [Abstract][Full Text] [Related]
17. Use of tumor necrosis factor in isolated hepatic perfusion.
Fraker DL; Alexander HR; Thom AK
Circ Shock; 1994 Sep; 44(1):45-50. PubMed ID: 7704938
[No Abstract] [Full Text] [Related]
18. Treatment options for liver metastases from colorectal cancer.
Lise M; Pilati P; Da Pian P; Mocellin S; Nitti D; Corazzino S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):149-56. PubMed ID: 16767922
[TBL] [Abstract][Full Text] [Related]
19. Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure.
Eggermont AM; van IJken MG; van Etten B; van der Sijp JR; ten Hagen TL; Wiggers T; Oudkerk M; de Boeck G; de Bruijn EA
Hepatogastroenterology; 2000; 47(33):776-81. PubMed ID: 10919031
[TBL] [Abstract][Full Text] [Related]
20. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
